Solution to the problem of tomographic scanning of objects by small area X-Ray detectors

Standard X-Ray tomographic setups basically consist of 3 parts: radiation source, mechanics for mounting a sample and detector system. Each part of tomographic setup in one way or another contributes into the quality of reconstructed images. Detector system is responsible for data acquisition process. Development of detectors improves them in terms of resolution, acquisition speed, dark current etc. Such improvements increases costs for producing of detectors as well as their final price. Tomographic scanning of long objects requires using detectors of corresponding size. It makes tomographic setups expensive, because the price of detectors also increases with increasing of their size. Presented work proposes to solve this problem by shifting detector along the longest dimension of the sample and applying optimized filtered backprojection algorithm

The diagnosis and management of anaphylaxis practice parameter: 2010 Update

These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council of Allergy, Asthma and Immunology. The AAAAI and the ACAAI have jointly accepted responsibility for establishing “The Diagnosis and Management of Anaphylaxis Practice Parameter: 2010 Update.” This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, or the Joint Council of Allergy, Asthma and Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion